Cancer and anti-inflammatory drugs

NEW YORK, June 19 (Praxis Press) Drugs such as aspirin, known as non-steroidal anti-inflammatory drugs (NSAIDs), are thought to reduce the risk of colon cancer, but whether these drugs decrease the risk of other types of cancers is unknown. A new study showed that people taking NSAIDs were at reduced risk of esophageal, gastric, colon, and rectal cancers (see paper). But no effect was apparent on the risk of bladder, breast, and lung cancer and the risk of prostatic and pancreatic cancer was inc

June 19, 2000

NEW YORK, June 19 (Praxis Press) Drugs such as aspirin, known as non-steroidal anti-inflammatory drugs (NSAIDs), are thought to reduce the risk of colon cancer, but whether these drugs decrease the risk of other types of cancers is unknown. A new study showed that people taking NSAIDs were at reduced risk of esophageal, gastric, colon, and rectal cancers (see paper). But no effect was apparent on the risk of bladder, breast, and lung cancer and the risk of prostatic and pancreatic cancer was increased. NSAIDs may protect against cancer of the gastrointestinal tract, but their role in reducing the risk of other cancers needs to be studied further.

Popular Now

  1. Decoding the Tripping Brain
  2. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

  3. Do Microbes Trigger Alzheimer’s Disease?
  4. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

AAAS